The Epley maneuver is a well-established, effective technique for treating vertigo — repositioning the tiny calcium crystals in your inner ear that have drifted out of place. But for a lot of people, the dizziness returns weeks or months later, requiring the maneuver again and again. The reason may be that the Epley maneuver addresses where the crystals ended up, without addressing why they became dislodged in the first place. (Based on the insights of Dr. Eric Berg)
Key Takeaways
- BPPV has a genuinely high recurrence rate (commonly cited around 50%) even with proper Epley maneuver treatment — recurrence isn’t unusual or a sign of doing it wrong.
- The vitamin D-BPPV link is a real area of research, but it’s genuinely debated — some studies find no clear relationship, suggesting the co-occurrence could be coincidental.
- Real research protocols correct a confirmed, tested vitamin D deficiency back to normal range — not blanket high-dose supplementation regardless of starting level.
- Sustained vitamin D above 4,000 IU/day (the NIH’s standard upper limit) carries real hypercalcemia risk without monitoring — testing and medical guidance matter for higher, sustained doses.
- Estrogen affects vitamin D receptor sensitivity, which may help explain why BPPV is more common in women after menopause.
What’s Actually Happening
Tiny calcium crystals normally sit attached to small hair-like structures inside your inner ear, helping you sense your position in space. This condition — benign paroxysmal positional vertigo, or BPPV — is the most common type of vertigo, and it happens when those crystals become dislodged and start floating in the wrong location, triggering dizziness. It’s also worth knowing that BPPV is a recognized condition with a genuinely high recurrence rate even with standard treatment — commonly cited around 50% — so recurrence itself isn’t unusual or a sign that anything was done wrong.
Those crystals are normally held in place by a calcium-binding protein called osteopontin. When this protein becomes elevated beyond its normal range, it can degrade the connection holding the crystal in place, contributing to it breaking loose.
The Vitamin D Connection — And Why It’s Still a Developing Area of Research
Vitamin D plays a role in regulating calcium throughout the body, including, some researchers propose, this calcium-binding protein specifically. It’s worth being clear about where the science currently stands: several studies have found an association between low vitamin D levels and both the occurrence and recurrence of BPPV, and there’s a real, published meta-analysis specifically examining vitamin D supplementation and BPPV recurrence. That said, this connection is genuinely still debated in the research community — other studies have found no clear relationship, with some researchers suggesting the co-occurrence of vitamin D deficiency and BPPV could simply be coincidental rather than causal, since both become more common with age. This is an active, evolving area of research rather than a fully settled question.
Why This Shows Up More After Menopause
BPPV is more common in women after menopause, and one proposed explanation involves estrogen’s effect on vitamin D receptor sensitivity — as estrogen drops significantly during menopause, vitamin D receptors may become less responsive, meaning the vitamin D already in your system may become less effective at doing its job. This would help explain why BPPV, osteopenia, and osteoporosis often cluster together in the same population, since all three involve calcium regulation gone awry.
What the Actual Research Protocols Look Like
It’s important to be precise here, since this affects how to actually apply this information safely. The research on vitamin D and BPPV recurrence generally involves first confirming an actual vitamin D deficiency through a blood test (measuring 25-hydroxyvitamin D), then correcting that deficiency back into a normal range — not simply taking a large, fixed dose of vitamin D regardless of your starting level. One referenced study, for example, looked at adults with confirmed low vitamin D (under 10 ng/mL) and found lower BPPV recurrence among those who raised their levels back above that threshold through supplementation.
This distinction matters for safety. Sustained vitamin D intake above 4,000 IU per day (the standard tolerable upper limit set by the National Institutes of Health for general use) can lead to excess calcium in the blood (hypercalcemia) over time if not monitored, which carries its own real health risks. Taking a large, fixed daily dose indefinitely without knowing your actual vitamin D level is a different, less evidence-based approach than the deficiency-correction protocols used in the actual research. The safer, more evidence-aligned approach: get your vitamin D level tested first, and work with your doctor to correct any deficiency to a normal range, with periodic monitoring if using a higher dose for an extended period.
Supporting Nutrients
Vitamin K2 is frequently discussed alongside vitamin D, since it helps direct calcium toward bone and teeth rather than soft tissue. Magnesium also plays a supporting role as a cofactor — without adequate magnesium, both vitamin D and vitamin K2 are less able to function properly, and magnesium deficiency is relatively common. A reasonable, well-tolerated magnesium dose commonly referenced is around 400 mg of magnesium glycinate daily, though as with any